IP Library Granted Patent US 8,293,904
Granted Patent B2
US 8,293,904 · App. 13/236,838 · Granted Oct 23, 2012

Electrochemical affinity biosensor system and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,904
App. No.
13/236,838
Granted
Oct 23, 2012
Kind
B2
Abstract

The present invention provides novel osmium-based electrochemical species for the detection of wide variety of analytes using immunological techniques. The present invention also provides diagnostic kits and test sensors supporting electrode structures that can be used with the osmium-based electrochemical species. The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of the electrical signal amplification desired to analyze analytes that may be present at low concentrations.

Claims (10)

1. A compound of the formula III:

wherein, R and R 1 are the same or different and each can be selected from: 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, 5-5′-disubstituted-2,2′-bipyridyl, 1,10-phenanthrolinyl, 4,7-disubstituted-1,10-phenanthrolinyl, 5,6-disubstituted-1,10-phenanthrolinyl, or N,N′-dimethyl 2, 2′-biimidazole, wherein each substituent is a methyl, ethyl, or phenyl group, and where the R and R 1 groups are coordinated to Os through their nitrogen atoms, R 2 is a saturated or unsaturated, substituted or unsubstituted, straight or branched chain, hydrocarbyl group having 1-10 carbon atoms; —R 3 is H, CH 3 or C 2 H 5 ; L is (CH 2 ) i Q wherein i is an integer between 1 and 10, and Q is O, S, or NR 3 ; B is a group comprising a ligand capable of binding to a specific analyte binding partner; X is a counter ion; y is selected to provide a neutral salt; and m is from 4-8.

2. The compound of claim 1 wherein R and R 1 are the same and are selected from 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, or 5-5′-disubstituted-2,2′-bipyridyl substituted with a methyl, an ethyl or a phenyl group.

3. The compound of claim 1 wherein L is —(CH 2 ) n NR 3 and n is an integer between 1 and 10.

4. The compound of claim 1 wherein the substituent R 2 is a saturated aliphatic group having between 1 and 10 carbons.

5. The compound of claim 1 wherein B comprises an epitope recognizable by an antibody capable of specific binding to an analyte.

6. The compound of claim 1 wherein B comprises an epitope capable of binding to an analyte selected from the group consisting of: a biowarfare agent, an abused substance, a therapeutic agent, an environmental pollutant, a protein or a hormone.

7. The compound of claim 1 wherein L is —(CH 2 ) n S and n is an integer between 1 and 10.

8. The compound of claim 1 wherein X is selected from the group of:

chloride, bromide, iodide, fluoride, tetrafluoroborate, perchlorate, nitrate, sulfate, carbonate, and sulfite.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2012
From: DIEBOLD, ERIC R.; GHOSHAL, MITALI; DENG, DAVID Z.; TSAI, JANE S.C.
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 027705/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2011
From: DIEBOLD, ERIC R., MR.; GHOSHAL, MITALI; DENG, DAVID Z., MR.; TSAI, JANE S.C., MS.
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 027141/0868 →